Liver Cancer Screening Rates Doubled With Mailed Orders
Liver cancer screening among patients with cirrhosis almost doubled when they were mailed a signed order from their specialist.
Read MorePosted by Chris Wolski | Dec 25, 2023 | Unknown Origin & Other Cancer Types |
Liver cancer screening among patients with cirrhosis almost doubled when they were mailed a signed order from their specialist.
Read MorePosted by Andy Lundin | Oct 16, 2023 | Immunoassay Reagents & test Kits |
Werfen announced 510(k) clearance of Aptiva Connective Tissue Disease (CTD) Essential reagent by the U.S. Food and Drug Administration (FDA).
Read MorePosted by Andy Lundin | Sep 28, 2023 | Infectious Diseases |
A team of researchers developed a new cost-effective method to diagnose and predict HBV-related diseases based on blood tests.
Read MorePosted by Andy Lundin | Sep 14, 2023 | Disease States |
AXIM’s assay uses a tiny teardrop to collect a fluid sample and can be run at a doctor’s office with results in less than 10 minutes.
Read MorePosted by Andy Lundin | Sep 8, 2023 | Disease States |
Octave Bioscience announced the publication of the successful clinical validation of its Multiple Sclerosis Disease Activity (MSDA) Test.
Read More